Page last updated: 2024-09-03

efegatran and benzoyl-norleucyl-lysyl-arginyl-arginal

efegatran has been researched along with benzoyl-norleucyl-lysyl-arginyl-arginal in 1 studies

Compound Research Comparison

Studies
(efegatran)
Trials
(efegatran)
Recent Studies (post-2010)
(efegatran)
Studies
(benzoyl-norleucyl-lysyl-arginyl-arginal)
Trials
(benzoyl-norleucyl-lysyl-arginyl-arginal)
Recent Studies (post-2010) (benzoyl-norleucyl-lysyl-arginyl-arginal)
4330600

Protein Interaction Comparison

ProteinTaxonomyefegatran (IC50)benzoyl-norleucyl-lysyl-arginyl-arginal (IC50)
Genome polyproteinWest Nile virus6.0667
Genome polyproteinDengue virus 2 Thailand/NGS-C/19446.0667
Genome polyproteinDengue virus 1 Nauru/West Pac/19746.0667
Genome polyproteinDengue virus 2 Tonga/EKB194/19746.0667
Genome polyproteinDengue virus 3 Philippines/H87/19566.0667
Genome polyproteinDengue virus 1 Singapore/S275/19906.0667
Genome polyproteinDengue virus 4 Philippines/H241/19566.0667
Genome polyproteinDengue virus 3 Sri Lanka/1266/20006.0667

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costanzo, MJ; Maryanoff, BE1

Reviews

1 review(s) available for efegatran and benzoyl-norleucyl-lysyl-arginyl-arginal

ArticleYear
Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.
    Bioorganic & medicinal chemistry, 2008, Feb-15, Volume: 16, Issue:4

    Topics: Amidohydrolases; Enzyme Inhibitors; Heterocyclic Compounds; Humans; Ketones; Protease Inhibitors

2008